“`html
WASHINGTON, January 9, 2026
PCMA Names David Marin as New CEO Amidst PBM scrutiny
David Marin is stepping into the top role at the Pharmaceutical Care Management Association (PCMA) as scrutiny intensifies on pharmacy benefit managers (PBMs) and their role in rising drug costs. Marin was named president and chief executive of the PCMA, effective January 20, according to a release issued Thursday.
A New Leader for PBMs Amidst Growing Pressure
the PCMA has appointed a new CEO as lawmakers and regulators increase their focus on the pharmaceutical supply chain.
- Marin previously served as global head of government affairs, public policy and advocacy at Viatris.
- The PCMA spent $17.5 million on lobbying in 2024 as PBM reform bills were considered in Washington.
- Lawmakers plan to reintroduce bipartisan legislation aimed at increasing PBM transparency and accountability.
- The association also announced new hires in communications and state affairs.
Marin, a veteran lobbyist and pharmaceutical executive, takes the helm as PBMs-
served as interim CEO since late 2025. Lebens took on the role following the departure of JC Scott, who stepped down after seven years leading the institution in October 2025.
Prior to joining the PCMA, Marin held a leadership position at Viatris, a global pharmaceutical company reporting $14.7 billion in annual sales, where he oversaw government affairs and public policy.
Before his time at Viatris, marin was managing principal at the podesta Group, a Washington, D.C.-based lobbying firm. He left the Podesta Group around the time the firm ceased operations in late 2017 amid scrutiny related to special counsel Robert Mueller’s investigation.
New Additions to the PCMA Team
Along with Marin’s appointment, the PCMA announced Brendan Buck as its new chief communications officer. Buck brings experience from public affairs agency Seven Letter and over a decade on Capitol Hill, serving as a communications advisor and press secretary for Republican lawmakers. He also previously held a communications leadership role at AHIP, a major insurance industry lobby.
Last month, the PCMA also Related
